Proud to be volunteer-based, we direct 100% of our net proceeds to our donor hospitals. With the generous support of our donors and volunteers, we’re here to create a community of hope. Our goal is to bring hope to people affected by brain cancer, showing them we strongly believe a future without Brain Cancer is possible.
Every day approximately 27 Canadians are diagnosed with a brain tumour. For many types of brain cancer, there's still no cure. We are here to change that.
Brain Matters advancing the work of Dr. James Perry
Support from the Brain Matters Brain Cancer Charity is advancing the work of neuro-oncologist Dr. James Perry, who is developing promising new treatments for glioblastoma. This is the most common and most aggressive form of brain tumour, and current therapies are insufficient. Researchers at Sunnybrook and beyond are working hard to find better treatments for glioblastoma, including Dr. Perry. He is the Chairman of the Canadian Brain Tumor Consortium, which recently participated in a promising new trial testing a gene therapy platform developed by Tocagen Inc. This technology involves the surgical placement of a modified virus (TOCA FC) into a brain tumour, which allows its cells to absorb a type of chemotherapy that otherwise cannot penetrate the brain.
An investment from the Brain Matters Brain Cancer Charity enabled Dr. Perry to purchase an MRI coil to adapt Sunnybrook’s existing MRI technology for future brain tumour research and analysis.
By supporting Dr. Perry’s research, the Brain Matters Brain Cancer Charity has had a notable impact on his work. Your gift will ensure this momentum continues unabated in the months ahead
Supporting Dr. Michael Cusimano's work in neurosurgery and glioma brain tumours.
Dr. Cusimano is dedicated to improving the health outcomes and saving the lives of patients who are affiliated with glioma brain tumours. Brain Matters has helped advance Dr. Cusimano and his team with the latest, cutting-edge surgical technology. Proceeds from 2019 will go towards purchasing a new stereotactic system. Stereotactic machines are three dimensional coordination systems that make it possible for surgeons like Dr. Cusimano to locate the smallest targets in the brain and perform minimally invasive surgeries. This technology will not enable our neurosurgeons to locate the tiniest tumours with the greatest precision possible but it will also allow them to remove them safely and effectively - thus dramatically improving the health outcomes of patients.
Last year we donated $250,000K to two of Canada’s top hospitals pioneering what could be the next breakthrough in curing or managing brain cancer. This year, with your support, our goals remain ambitious. Proceeds will help us continue the fight against brain cancer with groundbreaking advances, potentially changing the way brain cancer patients are treated in the future. This year we will continue to support Dr. Michael Cusimano by helping to fund projects such as Laser Interstitial Thermal Therapy (LITT) and Dr. James Perry, world renowned neuro-oncologist in his development of promising new treatments for glioblastoma.
Be a part of something that matters.
Why Brain Cancer Needs Your Support
Brain cancer does not discriminate. Every day, 27 Canadians are diagnosed with a brain tumour, and there are more than 120 different types.
Most drugs, including many chemotherapies, can’t efficiently enter the brain to target tumours due to the “blood-brain barrier”. This means researchers and doctors are still searching to find effective treatments.
Brain tumours can have life-altering physical, cognitive, and psychological impacts on a patient’s life.
Brain Tumour Awareness Month 2020: Prof Antonio Di IevaMay 21st, 2020
Professor Antonio Di Ieva predicts and hopes that brain cancer will be a manageable chronic disease “much like diabetes” by 2030, and patients will have a vastly improved quality of life.Read More
New Hope for Hardest-to-Treat Brain CancerApril 19th, 2019
Canadian researchers have identified genes in brain cancer stem cells that fuel the growth and survival of glioblastoma in hopes their data will be mined to develop treatments targeting an aggressive tumour that claimed the life of Tragically Hip frontman Gord Downie.Read More
Uncertainty Drives Innovation in Brain TumoursAugust 15th, 2017
Dr. Adrienne Weeks discusses the life-altering effects of a malignant brain tumour, glioblastoma multiforme. She explains some of the research being done by her lab in hopes for a more promising future for brain tumour patients.WATCH VIDEO
Gord Downie Describes
October 12th, 2016
Gord Downie describes the impact of brain cancer, including memory loss.WATCH VIDEO
Who We Are
Board of Directors
To make a cheque donation
All contributions are tax deductible and will be gratefully acknowledged with a receipt.
Do you want to get involved, donate, or ask a question? We’d love to hear from you.
Or email us at